Patents/Inventors

Asya Grinberg

Lexington, MAUS27 patents

27 Patents

US125457362026
Actrii-binding Proteins and Uses Thereof
Acceleron Pharma Inc
0 cites
US124212952025
Tgf-beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof
Acceleron Pharma Inc.
0 cites
US123848472025
Cancer Therapy Involving an Anti-pd1 Antibody and a Multi-specific Binding Protein That Binds NKG2D, CD16, and a Tumor-associated Antigen
Dragonfly Therapeutics, Inc.
0 cites
US123848512025
Multi-specific Binding Proteins That Bind BCMA, NKG2D and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites
US123783182025
Proteins Binding NKG2D, CD16 and a Tumor-associated Antigen
DRAGONFLY THERAPEUTICS, Inc.
0 cites
US123657362025
ALK7 Binding Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US123382732025
Single-arm Type I and Type II Receptor Fusion Proteins and Uses Thereof
Accerelon Pharma Inc.
0 cites
US122757912025
Multi-specific Binding Proteins That Bind HER2, NKG2D, and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites
US122642002025
Antibody Variable Domains Targeting the NKG2D Receptor
Dragonfly Therapeutics, Inc.
0 cites
US122583802025
Alk4:actriib Heteromultimers and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US122408872025
Variant Actriib Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US122151572025
Multi-specific Binding Proteins That Bind CD33, NKG2D, and CD16, and Methods of Use
Dragonfly Therapeutics, Inc.
0 cites
US121577712024
Proteins Binding NKG2D, CD16 and CLEC12A
Dragonfly Therapeutics, Inc.
0 cites
US121448602024
ALK1 Receptor and Ligand Antagonists and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US121459702024
Twisted Gastrulation Polypeptides and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US121293002024
Antibody Variable Domains Targeting the NKG2D Receptor
Dragonfly Therapeutics, Inc.
0 cites
US120547532024
Methods of Treatment of Muscular Dystrophy with Alk4:actriib Heteromultimers
ACCELERON PHARMA Inc.
0 cites
US120425242024
Activin Type 2 Receptor Binding Proteins Methods of Making Them
Acceleron Pharma Inc.
0 cites
US120245632024
ALK7 Antagonists and Uses Thereof
Acceleron Pharma Inc.
0 cites
US119511562024
Methods for Treating Pulmonary Hypertension with a Ligand Binding Domain of a Tgf-beta Type II Receptor
ACCELERON PHARMA, Inc.
0 cites
US119393842024
Antibody Variable Domains Targeting the NKG2D Receptor
Dragonfly Therapeutics, Inc.
0 cites
US118847332024
Antibody Variable Domains Targeting the NKG2D Receptor
Dragonfly Therapeutics, Inc.
0 cites
US118345062023
Multi-specific Binding Proteins That Bind NKG2D, CD16, and a Tumor-associated Antigen for Activation of Natural Killer Cells and Therapeutic Uses Thereof to Treat Cancer
Dragonfly Therapeutics, Inc.
0 cites
US118276892023
Alk7:actriib Heteromultimers and Uses Thereof
ACCELERON PHARMA Inc.
0 cites
US117878642023
Heterodimeric Fc-fused Proteins
Dragonfly Therapeutics, Inc.
0 cites
US117084142023
ALK7 Binding Proteins and Uses Thereof
Acceleron Pharma Inc.
0 cites
US115902012023
Endoglin Peptides to Treat Fibrotic Diseases
ACCELERON PHARMA, Inc.
0 cites